ClinicalTrials.Veeva

Menu

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

S

Stellenbosch University (SU)

Status and phase

Completed
Phase 4

Conditions

Irritable Bowel Syndrome

Treatments

Other: Wash - out period
Drug: Placebo comparator
Other: Run in period
Drug: Lactobacillus plantarum 299v

Study type

Interventional

Funder types

Other

Identifiers

NCT01886781
N10-08-270

Details and patient eligibility

About

In patients with IBS, will supplementation with a probiotic demonstrate symptomatic efficacy and will the probiotic influence gut microflora and thus improve clinical outcomes, as compared to no intervention.

Full description

Conduct a study on nutrient intakes gastrointestinal microbiota and the effect of a probiotic, Lactobacillus plantarum 299v in irritable bowel syndrome patients.

Enrollment

81 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fulfillment of the Rome II criteria for IBS,
  • availability of at least one colonoscopy within the last three years,
  • aged 18 or older at the time of screening,
  • provision of written informed consent,
  • commitment of availability throughout the 12 week study period.

Exclusion criteria

  • major abdominal surgery in the past other than other than appendectomy, caesarean section, tubal laparoscopic cholecystectomy, abdominal wall hernia repair or/and hysterectomy,
  • current use of antibiotics,
  • history of organic intestinal disease,
  • pregnant or breastfeeding mothers,
  • chronic infectious disease like HIV or tuberculosis, and
  • unable to understand English or Afrikaans.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

81 participants in 4 patient groups, including a placebo group

Lactobacillus plantarum 299v
Experimental group
Description:
Lactobacillus plantarum 299v capsules
Treatment:
Other: Run in period
Drug: Lactobacillus plantarum 299v
Other: Wash - out period
Crytalline cellulose powder
Placebo Comparator group
Description:
Placebo capsule, filled with micro-crystalline cellulose powder
Treatment:
Other: Run in period
Other: Wash - out period
Drug: Placebo comparator
Run in period
No Intervention group
Description:
Run in period of one to two weeks, no treatment. At baseline randomization and treatment commenced.
Wash out period
No Intervention group
Description:
Wash out period of two weeks, no treatment.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems